Hospital Universitari Vall d'Hebron Research Institute
With
Instituto de Salud Carlos III
There is still an unmet need in acute migraine treatment, some patients don't respond properly to acute medication.
There are some interindividual differences in clinical characteristics of migraine attacks. These differences may determine the response to acute treatment. Describing the phenotypical differences between patients who are responders and patients non-responders will allow us to offer a personalized treatment.
The aim of the study is to determine which characteristics are associated with a response or a non-response to acute treatment with sumatriptan.
Participants will be asked to register the headache characteristics and accompanying symptoms during 4 spontaneous migraine attacks and its response to treatment with sumatriptan.
Age
18–45
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Migraine with or without aura diagnosis according to ICHD-3 criteria
\<8 migraine days per month
Be able to read, write and understand instructions.
Have internet access and mail address
Signing of the informed consent
You may not be if
Active preventive treatment for migraine
Active medication with an effect over the central nervous system
Serious physical or psychiatric condition
Cardiovascular or hepatic disease
Pregnant or breastfeeding women
Any triptan contraindication
Severe migraine attacks without previous response to triptans or NSAIDs
